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Introduction
Oxysterols are a large family of oxygenated cholesterol derivatives involved in many biological processes, such as cardiovascular disease, cholesterol homeostasis, apoptosis and gene transcription regulation [1, 2] . One member of this family, 25-hydroxycholesterol (25- A C C E P T E D M A N U S C R I P T OHC) inhibits the transport of cholesterol and phosphoinositides by targeting the ORD (OSBPrelated) domain of OSBP [3] . In addition, in the murine neuronal cell line CATH.a, 25-OHC down-regulates the cholesterol biosynthesis by inhibiting the transcription of cholesterol biosynthetic genes, sterol regulatory element binding transcription factor (SREBF) [4] .
Moreover, 25-OHC functions in the inflammasome generation and cell death [5, 6] .
OSBP-like proteins (OSBPLs) show different structures and functions, but similar way of transporting lipids to OSBP. Several members of OSBPLs are known to bind oxysterols [7] .
One is Oxysterol Binding Protein Like 2 (OSBPL2) bearing just an oxysterol binding domain.
Overexpression of OSBPL2 in mammalian cells alters cholesterol synthesis, esterification and efflux, and increases the amount of newly synthesized cholesterol transported from the endoplasmic reticulum to the cell surface [8] . OSBPL2 can bind to 25-OHC suppressing the expression of OSBPL2 in H295R cell lines markedly increases the levels of both cholesterol and 25-OHC [9, 10] . In turn, 25-OHC down-regulates the transcription of many genes by suppressing cleavage of sterol regulatory element-binding proteins in lipid metabolism, but the effect of 25-OHC on OSBPL2 is unknown [11] .
We have identified OSBPL2 as a new deafness-inducing gene in a Chinese family with a history of progressive hearing loss [12] . However, the mechanism has not yet been elucidated.
Recent research has found the elevated concentrations of 25-OHC in cells harboring OSBPL2 mutations.
This experiment was designed to clarify the mechanism behind OSBPL2 transcription induced by 25-OHC. Here we reported that the accumulation of 25-OHC reduced transcriptional activity and the expression of OSBPL2. The amount of 25-OHC will increase in OSBPL2 knockdown cells, which may cause the apoptosis of inner hair cells [10] . This finding may provide a new insight into the nature of deafness.
Materials and methods

Cell culture and treatment
A C C E P T E D M
A N U S C R I P T HeLa cells were preserved in our laboratory and cultured in Dulbecco's Modified Eagle's Medium (DMEM, Gibco, USA) supplemented with 10% fetal bovine serum (FBS, BI, USA), 100 U/mL penicillin and 100 μg/mL streptomycin (Gibco, USA) in a humidified atmosphere containing 5% CO2 at 37°C. HeLa cells were seeded into 6-well culture plates (JET BIOFIL, China) (3×10 5 per well). The next day the HeLa cells were treated with 25-OHC of different concentrations for different periods. After treatment, the HeLa cells were collected for further use.
RNA isolation and quantitative real-time PCR (qRT-PCR) analysis
Total RNA was isolated from HeLa cells using TRIzol reagent (Invitrogen, USA) and reverse-transcribed to cDNA (Vazyme, China). cDNA was amplified by in a StepOnePlus RealTime PCR System (Applied Biosystems, USA) with ChamQ SYBR qRT-PCR Master Mix (High ROX Premixed) (Vazyme, China) and specific primers. The qRT-PCR primers were listed in Table 1 and Table 3 . Minimum information of the publication of qRT-PCR experiments (MIQE Guidelines) was shown in the Supplementary Table S1 . The product length, PCR amplification efficiencies, and R 2 of each primer were documented in the Supplementary Table   S2 . The comparative CT method (2   −ΔΔCT ) was used to analyze gene expression. GAPDH served as an internal control [13, 14] .
Bioinformatics analysis of OSBPL2 promoter and construction of truncated vectors
The sequence of OSBPL2 promoter (−2023 bp to +206 bp) encompassing ATG start site was obtained from the National Center for Biotechnology Information (NCBI, http://www.ncbi.nlm.nih.gov/). Potential transcription factor binding sites were predicted by JASPAR network tool software (http://jaspar.genereg.net/). Genomic DNA was extracted from normal human blood with RelaxGene Blood DNA System (TIANGEN, China) and used as a template for PCR amplification with PrimeSTAR ® HS DNA Polymerase and GC Buffer (Takara Bio, Japan). The fragments were cloned into pGL3-Basic vectors (Promega, USA) and renamed Table 1 . Endotoxin-free plasmids were extracted with Endo-free Plasmid Mini Kit Ⅱ (Omega Bio-Tek, USA).
Transfection and dual-luciferase reporter assay
Truncated plasmids (0.8 μg) and 10 ng pRL-TK (Promega, USA) were transfected with lipofectamine 2000 (2 μl) into HeLa cells that grew in 24-well plates. Then, 24 h later, the cells were lysed and incubated with luciferin according to the manufacturer's instructions (Promega, USA). The luciferase activity of the promoter constructs was then normalized to the renilla luciferase activity derived from the pRL-TK vector.
Chromatin immunoprecipitation (ChIP) assay
We conducted ChIP assay using a ChIP Assay Kit (Beyotime, China) according to the Table 2 . % Input = 2( overnight. These membranes were washed for three times, followed by secondary antibodies IRDye 800CW goat anti-Mouse IgG, IRDye 680LT goat anti-Rabbit IgG (LI-COR, USA).
Western blotting
Signals were visualized with Odyssey® CLx Imaging System (LI-COR, USA).
Gene silencing by siRNA
SiRNA of TP53, SREBF2 (GenePharma, China) and PLAG1 (sc-38179) (Santa Cruz, USA) was transfected into HeLa cells with non-targeting control siRNA by X-tremeGENE siRNA Transfection Reagent (Roche, USA) according to the manufacturers' instructions. The HeLa cells harvested 24 h after transfection were assessed with Western blotting and qRT-PCR.
Construction of truncated promoter deletion and transcription factors
To define the binding sites of transcription factors on the promoter of the OSBPL2 gene, deletions of the human OSBPL2 promoter were constructed by PCR amplification using eleven pairs of primers ( Table 1 ). The promoter products were digested by Kpn Ⅰ and Hind Ⅲ restriction endonucleases. The OSBPL2 promoter of the pGL3-Basic vector was replaced by these deletion fragments, and then co-transfected with the pRL-TK plasmids, as described above. The coding sequences (CDSs) of PLAG1 (NM_002655.2) and NFYA (NM_002505. 4) were engineered by PCR (primers, Table 2 ) and cloned into pXJ40-Flag. The plasmids were transfected into HeLa cells as described above.
Statistical analysis
Data were presented as mean ± SEM (standard error of the mean). One-way ANOVA and
Bonferroni's post-tests were performed to compare the differences between the groups treated with 25-OHC in a time-or dose-dependent manner. Other statistical significance was determined using between-group t-test. P <0.05 was regarded as statistically significant.
Results
25-OHC down-regulated the expression of OSBPL2 gene
Previous results have demonstrated that silencing OSBPL2 leads to a 1.9-fold increase in OHC on the transcriptional activity of OSBPL2 promoter with a dual-luciferase assay. As expected, the luciferase reporter activities of these constructs were clearly suppressed by 25-OHC (Fig. 1E ). These results suggested that 25-OHC down-regulated OSBPL2 on mRNA and protein levels.
Identification of OSBPL2 transcription regulatory region induced by 25-OHC
To identify the transcriptional regulatory region of human OSBPL2 promoter, we cloned a 2229 bp fragment in human OSBPL2 gene 5'-regulatory region from -2023 bp to +206 bp, and constructed five truncated clones in the plasmid pGL3-Basic (P1, P2, P3, P4, P5). After we
transfected the truncated plasmids into HeLa cells, the transcriptional activity of P2 was approximately 2-fold stronger than that of the other constructs (except for P5) ( Fig. 2A) . Then, fragments P2 and P5 were used as templates to generate P2-a, P2-b, P2-c; and P5-a, P5-b, P5-c; respectively. Dual-luciferase reporter assays indicated that the promoter activity of P2 was approximately 2.5-fold stronger than that of P2-a. Similarly, P5-a and P5-b had notably stronger transcriptional activity than P5-b and P5-c, respectively. The above results indicated that the key elements bearing promoter activity were located in the following two regions: region Ⅰ (-1552 /-1447 bp) and region Ⅱ (-205/+110 bp) (Fig. 2B, 2C ). To determine the precise sequences responsible to the transcriptional activity in these two regions, we first prepared two truncated plasmids containing P2-d (-1552/-1447 bp and +110/+206 bp) and P5-a-a (-205/-109 bp and +110/+206 bp). Firstly, compared with P2-a, the luciferase activity of P2-d was significantly weaker, suggesting that region I (-1552/-1447 bp) did not have transcriptional activity. Besides, the luciferase activity of P5-a-a was dramatically lower than that of P5-a, indicating that the core promoter region was located in region Ⅳ (-109/+110 bp) rather than region Ⅲ (-205/-109 bp). In addition, the transcriptional activity of the plasmids containing region Ⅳ (-109/+110 bp) decreased when the transfected HeLa cells was treated with 25-OHC, indicating that region Ⅳ (-109/+110 bp) was indispensable for the 25-OHC effect. (Fig. 2D) . As predicted by bioinformatics, the region (-109/+110 bp) of the promoter encompassed several transcription factor-binding sites, such as PLAG1 zinc finger (PLAG1), transcription factor AP-2 alpha (TFAP2A), nuclear transcription factor Y subunit alpha (NFYA), nuclear respiratory factor 1 (NRF1) and ETS transcription factor (ELK4) (Fig. 2E ).
NFYA and PLAG1 were essential for basal transcriptional regulation of OSBPL2
To identify functional regulatory elements, the region between nucleotides -109 and +110
was predicted by online transcription factor binding sites prediction software. Various truncated plasmids were transfected into HeLa cells. Deleting transcription factor binding sites in PLAG1
and NFYA sharply decreased their activity by 70%~80%, suggesting that these two factors
played a major role in OSBPL2 promoter-driven basal transcription (Fig. 3A) . To test whether PLAG1 and NFYA bind to the promoter, we constructed two overexpression vectors. Then we transfected 2 μg of plasmid in each well. The protein was expressed highly enough to be used in the following experiments (Fig. 3B) . As shown in Fig. 3C , overexpression of both NFYA and PLAG1 significantly increased the transcription of OSBPL2. In the rescue experiment, we transfected the wild-type NFYA constructs into the NFYA-deletion (Δ-NFYA) group. The OSBPL2-transcription was rescued accordingly and PLAG1 showed the same response (Fig.   3C ). These results indicated that NFYA and PLAG1 were indispensable in the basal transcriptional regulation of OSBPL2.
NFYA participated in the transcriptional regulation of OSBPL2 induced by 25-OHC
Subsequently, we explored whether PLAG1 and NFYA bound to the OSBPL2 promoter. For putative NFYA binding sites (CCAAT), we designed three pairs of primers that can amplify the promoter region. The putative NFYA binding region was only amplified with the specific primer 2. ChIP-qRT-PCR results showed that transcription factor NFYA bound to the promoter of OSBPL2 (Fig. 4A) . Additionally, the putative PLAG1 binding region was only amplified with the specific primer 5, suggesting that transcription factor PLAG1 also bound to the promoter of OSBPL2 (Fig. 4B) Fig. 4C-D) . These results suggested that NFYA participated in the transcriptional regulation of OSBPL2 induced by 25-OHC.
RNA-Sequencing of 25-OHC treated HeLa cells
To elucidate why the excessive 25-OHC decreased the expression of OSBPL2, we carried 
p53/SREBF2 signaling pathway regulated 25-OHC-induced OSBPL2 expression
Intracellular 25-OHC generation can downregulate the expression of p53, which further suppresses the expression of SREBF2 [17] . As shown in Fig. 6A -D, after treating 25-OHC for 24 hours, intracellular mRNA and protein levels of p53 were shown to have been upregulated in a dose dependent manner. SREBF2, not NFYA, showed the opposite trend. We then examined how depletion p53 affected the SREBF2 and OSBPL2 expression and function. As shown in Fig. 6 E and I, the p53-specific siRNAs efficiently depleted the endogenous expression of p53 by up to 70%. Upon depleting p53 expression using siRNAs in Hela cells, the mRNA and protein levels of SREBF2 and OSBPL2 were significantly elevated (Fig. 6F, H and I). However, when 25-OHC was added to the TP53-knockdown cells, these levels returned to the normal (Fig. 6F, H and I) . Besides, the mRNA and protein expression of NFYA showed no change upon these treatments. To further identify the signaling pathway at the downstream of p53, we knocked down SREBF2 in HeLa cells using siRNA ( Fig. 6J and M) and found that the expression of NFYA did not change but that of OSBPL2 decreased (Fig. 6K , L and M), and when 25-OHC was added to the SREBF2-knockdown group, OSBPL2 transcription was unchanged compared with that in 25-OHC-induced group (Fig. 6L and M) .
A C C E P T E D M
A N U S C R I P T
Discussion
In this study we identified that NFYA and PLAG1 were essential for the basal transcription of OSBPL2 gene. 25-OHC down-regulated the expression of OSBPL2. TP53 was obviously upregulated mRNAs and SREBF2 down-regulated. Then we verified that these targets participated in transcriptional regulation of OSBPL2 induced by 25-OHC, indicating that the p53/SREBF2
signaling pathway regulates 25-OHC-induced OSBPL2 expression.
Targeted transportation of cholesterol is necessary for lipid metabolic homeostasis [18] .
Oxysterol-binding protein (OSBP), a group of intracellular lipid receptors, plays an important role in regulating cellular lipid homeostasis and in many cellular processes [19] . One of the OSBP family members, OSBPL2, was found to be associated with progressive nonsyndromic hearing loss, but the mechanism of disease progression was unclear [12, 20] . OSBPL2 binds to 25-OHC weakly [9] . Silencing OSBPL2 reduces the expression of steroidogenic factor 1 (SF1), leading to a 2.9-fold increase in cellular free cholesterol level, while this excessive cholesterol generates a 1.9-fold increase in the level of 25-OHC which was catalyzed by cholesterol hydroxylase [10] . In addition, 25-OHC downregulated cholesterol biosynthesis by inhibiting the transcription of SREBF [4] . On the other hand, we found that treatment of 25-OHC in cells inhibited the expression of OSBPL2 at the mRNA and protein levels. In addition, it had been reported that 25-OHC may accumulate in the OSBPL2 knockdown cells. These results indicated that the suppression of OSBPL2 expression could lead to accumulation of 25-OHC in vivo and result in cell apoptosis, which may provide a novel insight into understanding why OSBPL2 mutations cause a progressive hearing loss. In addition, recent studies have found that excessive 25-OHC in the central nervous system produces pro-inflammatory effects [5] . Besides, OSBPL2, was a lipid-sensing regulator of the actin cytoskeleton, raising the possibility that dysregulation of F-actin upon OSBPL2 depletion could be one causal factor [21] .
However, further study is needed to prove the hypothesis that 25-OHC can promote the cellular processes (like apoptosis) of osbpl2 -/-inner ear hair cells. We also investigated the molecular mechanism through which 25-OHC suppresses the transcription of OSBPL2. A previous study demonstrated that 25-OHC obviously increased the mRNA and protein levels of p53 [25] [26] [27] [28] , a process that inhibits the expression of SREBF2 [29] [30] [31] . Our results showed that excessive 25-OHC significantly upregulated p53 expression and downregulated SREBF2 expression, but had no effect on NFYA expression. Accordingly, silencing p53 and SREBF2 by RNA interference ended with similar results. Not only as tumor suppressor, p53 have also shown its role in metabolism, fecundity, cellular differentiation and development [32] . However, there is less evidence proving the link between p53 and cholesterol or oxysterol transport/metabolism. The significant increase in TP53 mRNA level in the SMC is
consistent with the finding that oxysterols (specifically 25-OHC) induce the up-regulation of p53 [25] . 7-Ketocholesterol and 25-OHC increased the level of p53 expression [33] . SREBF2 encodes a ubiquitously expressed transcription factor SREBF2 that controls cholesterol homeostasis by regulating the transcription of sterol-regulated genes. Previous analysis has showed that p53 overexpression suppresses the transcriptional activity of SREBF2 promoter gene and its downstream genes [30] . In addition, p53 also increases the level of large tumor suppressor kinase 2 (LATS2) which inhibits the expression SREBF2 and cholesterol accumulation [17, 34] . NFYA and NFYC activation domains recruit gene-specific regulatory factors (e.g., SREBF2s and C/EBP) that bind to the DNA to facilitate transcription activation [24] . Combining previous observations with our findings, we believe that SREBF2 can bind and activate NFYA. Therefore, it is reasonable to conclude that the p53/SREBF2 signaling pathway is responsible for the 25-OHC-suppressed OSBPL2 transcription.
In conclusion, NFYA is essential for the basal transcription of OSBPL2, and 25-OHC inhibits NFYA-dependent transcription of OSBPL2 via the p53/SREBF2 pathway. The present study provides a new insight into the molecular mechanism underlying the hearing loss caused by OSBPL2 mutation.
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